CD33 and myelodysplastic syndrome: In the same fashion, Gleason et al. documented a significantly enhanced activation and degranulation of CD16 × CD33 BiKE-induced NK in myelodysplastic syndrome (MDS) cells, irrespective of disease stage and karyotype features [60].